University of Rochester

 

Human Subject Studies

Which Require IBC Approval

 

 

 

Please choose one link which best describes your study and follow the corresponding instructions.

If none of the choices seem applicable to your study, contact Janet Ives, Biosafety Officer, at X53014 or jives@safety.rochester.edu.

 

Clinical study which involves the introduction of Recombinant DNA (plasmids) or gene transfer vectors (including viral vectors) into human subjects with or without specimen analysis.

 

Clinical study which involves introduction of genetically engineered micro-organisms or infectious agents into human subjects (including live vaccines if they are experimental in nature and/or not FDA-approved for use in the specific study population) with or without specimen analysis.

Clinical study which involves no introduction of the above mentioned agents to human subjects. However, sera, blood products or other specimens collected from the study participants will be processed for shipment, analyzed or experimented within UR research labs or in areas not considered clinical lab space.

 

QUESTIONS or COMMENTS?
Contact EH&S at (585) 275-3241 or e-mail EH&S Questions.

This page last updated 9/6/2012. Disclaimer.